期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CHEMOTHERAPY LetPub Score 5.1
50 ratings
Rate
Reputation 6.4 Influence 3.7 Speed 7.0 | ||||||||||||||||||||||||||||||||
期刊簡稱 | CHEMOTHERAPY | ||||||||||||||||||||||||||||||||
ISSN | 0009-3157 | ||||||||||||||||||||||||||||||||
E-ISSN | 1421-9794 | ||||||||||||||||||||||||||||||||
h-index | 49 | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | http://www.karger.com/Journal/Home/223834 | ||||||||||||||||||||||||||||||||
在線稿件提交 | http://oper1.karger.com/xpresstrack/submissions/?jid=144 | ||||||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||||||
出版商 | S. Karger AG | ||||||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||||||||
創刊年 | 1968 | ||||||||||||||||||||||||||||||||
每年文章數 | 29每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 17.00% | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-3157%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CHEMOTHERAPY] 的評論 | 撰寫評論 |
作者: 北风芊芊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-20 13:39:27 評論於 This article requires 80 references?!(0) 讚! | 北风芊芊 |
作者: 北风千波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 15:56:13 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Experience sharing: Submitted on 2022.12.8, revised format on 2023.1.4, external review started on 2023.1.17, major revisions delayed due to the Spring Festival, revisions completed on 2023.3.13, formally accepted on 2023.3.20(0) 讚! | 北风千波 |
作者: 通背若淑 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-06 15:13:51 評論於 Are there any great contributors recently? It seems very difficult to submit to this magazine as they only publish over 50 articles per year(0) 讚! | 通背若淑 |
作者: 雷电红瑞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-02 19:27:44 評論於 Review speed: 1.0 | Submission hit rate: 50.0 Experience Sharing: Just submitted, rejected in four days, reason given was lack of innovation in the topic, language barrier(0) 讚! | 雷电红瑞 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 14:09:06 評論於 Anyway, this is the look of the bear, there will be no change, as long as it doesn't fall, it's fortunate enough(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 23:04:50 評論於 Crossed over 2 points, will it be a bit more exciting next year, very hopeful(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-08-25 12:30:38 評論於 Review process lasted for six months, with over a dozen questions raised, but they were not very sharp and did not require additional experiments. After one month of preparation, the paper was resubmitted and quickly accepted!(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-04-01 12:39:42 評論於 It has been four months and still no news, so slow!(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us